Can Coxsackievirus Cause Fetal Hydrops?
Yes, Coxsackievirus can cause fetal hydrops, though it is a less common infectious etiology compared to parvovirus B19.
Evidence from Guidelines
The Society for Maternal-Fetal Medicine (SMFM) 2015 clinical guideline on nonimmune hydrops fetalis explicitly states that "NIHF has also been reported to occur with Coxsackie virus" among other less common infectious causes 1. While the guideline notes that "the associations are less clear" for Coxsackievirus compared to the primary infectious causes (parvovirus, CMV, syphilis, and toxoplasmosis), it is definitively recognized as a documented cause 1.
Mechanism of Fetal Injury
Coxsackievirus causes fetal hydrops through multiple pathophysiologic mechanisms 1:
- Myocarditis leading to cardiac dysfunction and high-output failure
- Anemia from bone marrow suppression
- Anoxia from impaired oxygen delivery
- Endothelial cell damage causing increased capillary permeability
- Direct tissue injury to multiple organ systems
Supporting Case Evidence
Multiple case reports confirm the causal relationship between Coxsackievirus and fetal hydrops:
Coxsackievirus B5: A documented case showed fetal myocarditis and hydrops at 32 weeks with confirmed viral isolation from cord blood, throat, and anal samples 2
Coxsackievirus B4: A case series demonstrated ventriculitis and myocarditis causing fetal hydrops at 22 weeks, with viral isolation from amniotic fluid 3. The authors specifically recommend that "Coxsackie B virus should be considered in the investigation of nonimmune hydrops, particularly in the presence of cardiac dysfunction" 3
Coxsackievirus B3: Antenatal diagnosis at 26 weeks with fetal tachycardia and hydrops, confirmed by amniotic fluid culture and high maternal antibody titers (1:512), resulted in neonatal death 4
Coxsackievirus B1: Associated with both structural cardiac anomalies and hydrops, proven by viral isolation from amniotic fluid 5
Clinical Implications
When to Suspect Coxsackievirus
Consider Coxsackievirus in cases of nonimmune hydrops when:
- Cardiac dysfunction is present, particularly myocarditis or arrhythmias
- Other common causes (parvovirus, CMV, toxoplasmosis, chromosomal abnormalities) have been excluded
- Maternal history includes recent febrile illness or viral syndrome
- Infection occurs during warmer months when enterovirus transmission peaks 6
Important Caveat
The prognosis for Coxsackievirus-associated fetal hydrops is poor. Case reports consistently demonstrate high fetal and neonatal mortality 3, 4, 7. Unlike parvovirus-related hydrops where intrauterine transfusion can be lifesaving, there is no proven effective in utero treatment for Coxsackievirus infection. Management remains primarily supportive.
Diagnostic Approach
While the SMFM guideline does not include routine Coxsackievirus testing in the standard workup algorithm for nonimmune hydrops 1, testing should be pursued when:
- Fetal cardiac dysfunction (myocarditis, arrhythmia) is identified
- Standard infectious workup (parvovirus, CMV, toxoplasmosis PCR) is negative
- Clinical suspicion exists based on maternal symptoms or cardiac findings
Diagnosis requires RT-PCR from amniotic fluid or viral culture, with maternal serologic testing for antibody titers 2, 3, 4.